Share This Page
Drug Price Trends for NDC 00904-2528
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-2528
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LICE KILLING SHAMPOO | 00904-2528-20 | 0.04742 | ML | 2025-03-19 |
| LICE KILLING SHAMPOO | 00904-2528-20 | 0.04784 | ML | 2025-02-19 |
| LICE KILLING SHAMPOO | 00904-2528-20 | 0.04839 | ML | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-2528
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00904-2528
Introduction
The drug identified by NDC 00904-2528 is a prescription medication whose market trajectory and pricing dynamics are influenced by multiple factors, including therapeutic category, patent status, regulatory environment, competition, and healthcare policies. Given the recent trends in pharmaceutical innovation and market evolution, an in-depth analysis provides critical insights for stakeholders seeking strategic positioning and investment decisions.
Drug Overview and Therapeutic Context
NDC 00904-2528 is associated with a [specific medication], prescribed primarily for [main indication], which addresses a significant healthcare need. Its pharmacological profile indicates [key features], aligning it with treatments for [particular diseases or conditions]. The therapeutic area’s growth potential is driven by increasing prevalence rates, unmet clinical needs, and expanding indications.
Market Landscape and Competitive Dynamics
Market Size and Growth Potential
The global market for [therapeutic class or disease focus] is projected to reach $X billion by 20XX, expanding at a compound annual growth rate (CAGR) of X% (source: [industry report, e.g., IQVIA, EvaluatePharma]). The market growth is underpinned by rising disease prevalence, accelerated diagnosis rates, and evolving treatment paradigms favoring innovative therapies.
The specific segment for NDC 00904-2528 is further segmented based on age groups, geographic regions, and disease severity. North America dominates the market due to high healthcare penetration and reimbursement coverage, accounting for approximately X% of total sales, with Europe and Asia-Pacific as expanding regions.
Competitive Landscape
NDC 00904-2528 competes with several other formulations, including branded drugs like [competitor 1], [competitor 2], and biosimilar versions entering markets as patent protections expire. The competitive intensity is affected by:
- Patent lifecycle and exclusivity periods
- Pricing strategies of competitors
- Clinical efficacy and safety profiles
- Formulation advantages such as delivery method or reduced dosing frequency
Key players are investing heavily in post-market clinical trials, patient support programs, and digital health partnerships to differentiate products.
Regulatory and Reimbursement Environment
Regulatory approvals from agencies such as FDA and EMA have been pivotal—whether the drug enjoys full approval or accelerated pathways influences market entry timing and attractiveness. Reimbursement policies, cost-effectiveness evaluations, and formulary placements significantly impact adoption rates and revenue potential.
Price Analysis and Trends
Current Pricing Landscape
The average wholesale price (AWP) for NDC 00904-2528 ranges from $X to $Y per unit, depending on dosage and formulation. Commercial and Medicare Part D insurers negotiate significant discounts and rebates, typically reducing the net price by 20-30% (source: SSR Health).
Factors Influencing Price Dynamics
-
Patent Status: With patent expiration imminent in [year], generic entry is expected to lead to a substantial price erosion, typically 50-70% within the first 2 years post-generic launch.
-
Regulatory Changes: Accelerated approvals or supplemental indications can temporarily buoy prices due to increased market potential.
-
Market Competition: Entry of biosimilars or alternative therapies could pressurize pricing, especially in saturated segments.
-
Manufacturing Costs and Supply Chain: Fluctuations in raw material costs and supply chain efficiencies influence pricing strategies and profit margins.
Future Price Projections
Given current patent protections until [year], subsequent biosimilar entry, and market adoption trends, the expected price trajectory over the next five years is:
- Years 1–2: Stable prices at approximately $X per dose, with minor adjustments for inflation and value-based pricing models.
- Year 3 and beyond: Prices may decline by 20-50% following patent expiration and generic/biosimilar market entries.
- Post-patent: Projected net price averages could fall to $Y−$Z per dose, based on benchmarks from similar drug classes.
Additionally, manufacturers might employ strategic measures such as tiered pricing, patient discounts, or value-based agreements to sustain revenues post-patent expiry.
Revenue and Market Share Projections
Based on epidemiological data and current adoption rates:
- Short-term (1-2 years): Anticipated sales of $A million, capturing a market share of approximately X%, driven by early adopters and formulary placements.
- Mid-term (3-5 years): Revenue could increase to $B million due to expanding indications, increased clinical adoption, and expanded geographic access.
- Long-term (beyond 5 years): Revenue potential depends on generic competition dynamics; full market penetration may decline, but pipeline expansions and new formulations could sustain revenues.
Market share is expected to decline by Y% post-patent expiry unless offset by new indications or formulations.
Strategic Implications for Stakeholders
- Pharmaceutical Companies: Need to invest in lifecycle management strategies—such as new formulations, combination therapies, and obtaining additional indications—to mitigate patent cliff impacts.
- Payers: Adoption of value-based pricing models and outcome-driven reimbursement could optimize costs and ensure access.
- Investors: Analyzing patent expiration timelines and competitive landscape shifts are critical for valuation and investment timing.
- Regulators: Streamlining approval processes for biosimilars and generics could influence future pricing and market competitiveness.
Key Takeaways
- Market Potential: The therapeutic area for NDC 00904-2528 exhibits sustained growth driven by increasing disease prevalence and expanding indications.
- Pricing Outlook: Price erosion is imminent following patent expiry, but strategic pricing, value demonstration, and pipeline development can prolong profitability.
- Competitive Risks: Entry of biosimilars and generics will significantly influence market shares and profitability.
- Regulatory Environment: Regulatory approvals and reimbursement policies will remain pivotal, with accelerated pathways providing early market opportunities.
- Strategic Focus: Companies should prioritize lifecycle management, diversification, and demonstration of clinical value to safeguard market position.
FAQs
1. What is the patent status of NDC 00904-2528, and how does it affect pricing?
The patent is valid until [year], after which biosimilar and generic competitors are likely to enter, causing a significant decline in drug prices.
2. How does competition influence future price projections for this drug?
Intense competition from biosimilars or cheaper alternatives can reduce prices by up to 50-70%, impacting revenue projections substantially.
3. What are the key factors that determine reimbursement levels for this medication?
Regulatory approval, clinical efficacy, cost-effectiveness, and formulary negotiations shape reimbursement levels, affecting net pricing and market penetration.
4. Are there any opportunities for lifecycle extension for NDC 00904-2528?
Yes. Additional indications, new formulations, or combination therapies can extend market exclusivity and sustain revenues.
5. How will emerging healthcare policies impact the market?
Policies prioritizing value-based care and permitting biosimilar adoption can lead to price reductions and altered market dynamics.
Sources
- EvaluatePharma. "Global Forecast Insight." 2022.
- IQVIA Institute. "The Impact of Biosimilars on the Healthcare Market." 2022.
- SSR Health. "Pharmaceutical Pricing Trends." 2022.
- FDA. "Drug Approval and Patent Data," 2022.
- Industry Reports and Market Analyses.
Note: Exact drug-specific details such as the drug’s name, indications, and patent expiration date are assumed placeholders needing specific, up-to-date data for precise analysis.
More… ↓
